| abstract |
Provided herein are methods for treating a cancer, the methods comprising administering to a subject in need thereof: i) a multispecific protein comprising a CD123 binding domain and a CD3 binding domain; and ii) a second anti-cancer agent. The anti-cancer agent used in the methods described herein, may be, for example a chemotherapeutic drug. In some embodiments, the chemotherapeutic drug is venetoclax, azacitidine, decitabine, daunorubicin, cytarabine, idarubicin, mitoxantrone, or etoposide. |